IESE (España)
-
GeneRisk.com
Johnson, RobCase E-67Entrepreneurship, Innovation and ChangeA mediados del año 2000, los inversores en Medical Sciences Limited (MSL) consolidaron una nueva compañía, GeneRisk.com, para concentrar su capital en una herramienta de software propiedad de MSL. La inmediata cuestión planteada a los inversores de MSL fue cómo evaluar esta nueva compañía para la siguiente tanda de financiación.Starting at €8.20
-
Lindberg Capital
Johnson, RobCase E-197EntrepreneurshipEl caso describe cinco oportunidades de inversión en start-ups enviadas a una empresa de capital riesgo. La empresa recibe demasiados planes de negocio como para reunirse con todos los equipos directivos, por lo que deben seleccionar cuidadosamente las ideas con el fin de decidir con qué equipos vale la pena reunirse. Caso basado en el caso E-68 («Nova Capital») del mismo autor.Starting at €8.20
-
Nova Capital (Portuguese Version, Brazil)
Johnson, RobCase E-235-PBEntrepreneurshipAndré Payard, a newly hired at Nova Capital, had to develop an approach for making initial assessments of the large number of business plans received by the Dutch venture capital firm. He knew that his team could not meet with the management teams from all of the businesses, so it was crucial to select those plans with the greatest potential before schedulling management presentations. Este caso está basado en el caso "Nova Capital", E-68, del mi...Starting at €8.20
-
Nova Capital
Johnson, RobCase E-235-EEntrepreneurshipAndré Payard, a newly hired at Nova Capital, had to develop an approach for making initial assessments of the large number of business plans received by the Dutch venture capital firm. He knew that his team could not meet with the management teams from all of the businesses, so it was crucial to select those plans with the greatest potential before schedulling management presentations. Este caso está basado en el caso "Nova Capital", E-68, del mi...Starting at €8.20
-
Tradetix Limited (B)
Johnson, RobCase E-204-EEntrepreneurship, FinanceThe (A) case describes a fast-growing company in the City of London whose CEO and board are considering initiating a trade sale process. The (B) case describes an offer received, which includes an earn-out as part of the price. The (C) case describes a sequence of events following acceptance of the offer-events that are totally unexpected and that jeopardize the earn-out.Starting at €5.74
-
Tradetix Limited (C)
Johnson, RobCase E-205-EEntrepreneurship, FinanceThe (A) case describes a fast-growing company in the City of London whose CEO and board are considering initiating a trade sale process. The (B) case describes an offer received, which includes an earn-out as part of the price. The (C) case describes a sequence of events following acceptance of the offer-events that are totally unexpected and that jeopardize the earn-out.Starting at €5.74
-
GeneRisk.com
Johnson, RobCase E-67-EEntrepreneurship, Innovation and ChangeIn mid-2000 the investors in Medical Sciences Limited (MSL) set up a new company, GeneRisk.com, to capitalize on a proprietary software tool owned by MSL. The immediate issue facing MSL's investors was how to value this new company for the upcoming round of financing.Starting at €8.20
-
Accolade Group
Kolarova, Lenka; Johnson, RobCase E-225-EFinanceIn September 2005, John Allen, the Chairman and founder of Accolade Group, leaned back in the armchair in his office and reflected on the developments in his company over the past nine years. Allen had a lifelong career in the UK leisure industry, culminating in his founding of the Accolade Group through a £279m management buy-in (MBI) of the Accolade Bingo business from Guss, a quoted UK-based leisure company, in 1997. Allen had a vision that un...Starting at €8.20
-
The Coffee Table
Johnson, Rob; Pinto, MauriceCase E-190-EEntrepreneurship, FinanceThis case describes how the entrepreneur financed an innovative coffee shop chain from start-up through multiple stages of growth. The company raised £12.6 million over six rounds of financing and needs another £9-11 million at the end of the case. The entrepreneur must decide whether (a) to press ahead with another round of capital to fund further expansion, (b) to stop opening new shops and focus on becoming profitable, or (c) to sell the com...Starting at €8.20
-
Nova Capital
Johnson, RobCase E-235EntrepreneurshipAndré Payard, recientemente contratado en Nova Capital, debía de desarrollar una propuesta con el fin de realizar una valoración inicial del gran volumen de planes de negocios que recibía la compañía holandesa de capital riesgo. Era consciente de que su equipo no podría entrevistarse con los directores de todos los equipos de negocios, así que era determinante seleccionar aquellos planes con mayor potencial antes de planificar las presentaciones...Starting at €8.20